Senate Ag committee to take OTC derivatives transparency to new levels

Capitol Hill

The declaration was made in a letter to four fellow senators on April 13, ahead of the expected introduction of a draft bill as early as today. If included, the reporting requirement would go further than what has been proposed in both the Wall Street Reform and Consumer Protection Act, passed in the House of Representatives on December 11, and a version of the bill introduced by Christopher Dodd, the chairman of the Senate Committee on Banking, Housing and Urban Affairs, on March 15.

"My bill

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: